Gilde Healthcare strengthens Investor Relations and Fundraising team with Besmire Ahmati - Gilde Healthcare

Gilde Healthcare strengthens Investor Relations and Fundraising team with Besmire Ahmati

9 juni 2023
Utrecht (The Netherlands)

Gilde Healthcare, a leading transatlantic investment firm specialized in the healthcare sector, is pleased to announce the addition of Besmire Ahmati to its team as Associate Investor Relations and Fundraising.

In this new role, Besmire will focus on supporting Gilde Healthcare’s investor relations activities and contribute to the firm’s capital raising and communications efforts. With over 5 years of experience in financial services and more recently as an LP investor, Besmire brings valuable expertise to Gilde Healthcare.

“We are pleased to welcome Besmire to our Investor Relations and Fundraising team,” said Pieter van der Meer, Managing Partner of Gilde Healthcare. “Her experience with institutional investors such as PGGM and FMO, strong industry relationships, and entrepreneurial mindset will help in building out our fundraising strategy and investor relationships.”

Prior to joining Gilde Healthcare, Besmire was part of the PGGM Private Equity team as a Junior Investment Manager investing in a global portfolio of private equity funds and co-investments. Prior to that, Besmire worked as a portfolio analyst in distressed assets transactions in private markets for FMO – the Dutch Entrepreneurial Development Bank. She began her career at Van Lanschot Kempen as an investment graduate.

“I am honored to be a part of Gilde Healthcare’s exceptional team and contribute to the firm’s continued success. I look forward to collaborating with our existing and prospective investors, delivering exceptional service, and fostering long-term partnerships with our stakeholders.” said Ahmati.

About Gilde Healthcare
Gilde Healthcare is a specialized healthcare investor managing over €2.5 billion across two fund strategies: Venture&Growth and Private Equity. The Venture&Growth fund of Gilde Healthcare invests in fast growing companies active in digital health, medtech and therapeutics, based in Europe and North America. The Private Equity fund of Gilde Healthcare participates in profitable lower mid-market healthcare companies based in North-Western Europe. For more information, visit the company’s website at www.gildehealthcare.com.

Meer nieuws

Boston Scientific to Acquire Nalu Medical

We are pleased to announce the strategic exit of our portfolio company Nalu Medical. Boston Scientific, a global leader in medical technology, has agreed to acquire Gilde Healthcare portfolio company Nalu Medical at a $600m valuation....
17 oktober 2025

Gilde Healthcare company Tagworks Pharmaceuticals Announces CTA Authorization and Initiation of Phase 0/1 Clinical Trial for TGW211, a Radiopharmaceutical for the Treatment of HER2+ Tumors

TGW211 is a next-generation, first-in-class HER2-directed radioimmunoconjugate developed based on Tagworks’ proprietary Click-to-Release – bioorthogonal, in vivo click chemistry – linker platform TGW211 is designed to achieve strong tumor uptake with selective and rapid elimination...
15 oktober 2025

Gilde Healthcare company SpyGlass Pharma’s Novel BIM-IOL System Demonstrated a Statistically Significant Reduction in Mean IOP at 24 Months

42% reduction in mean intraocular pressure (IOP) compared to baseline (p<0.0001) 100% of patients were off all topical IOP-lowering medications at 24 months 100% of treated patients achieved 20/30 or better Best Corrected Distance Visual...
14 oktober 2025